Floatz logo

BMS-986345

Anaplastic Large Cell Lymphoma

Memorial Sloan Kettering Cancer CenterPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

33 Active assets in the Anaplastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Inno-206
Children's Cancer Group, China
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
(+)-VINCRISTINE
Seagen Inc.
Phase 4BBB
Ifosfamide
National Cancer Institute (NCI)
Phase 4BB
METHOTREXATE
Children's Cancer Group, China
Phase 4BB

View all 50 →

Same molecule, other indications

BMS-986345 is also rated in:

Chronic Lymphocytic LeukemiaDormant
B
Indicative ·
58 / 100
View asset →
Follicular LymphomaDormant
B
Indicative ·
56 / 100
View asset →
Indolent Non-Hodgkin LymphomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →